| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |